Dominica vs Yemen: Tuberculosis patients living with HIV receiving antiretroviral therapy
Dominica
0 patients
in 2021
Yemen
0 patients
in 2020
Dominica rank
141st
Yemen rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Dominica
- Yemen
How they compare
Dominica currently reports 0 patients against 0 patients in Yemen, a difference of 0 patients.
The two have swapped places 4 times across 10 shared years of data; in 2006 it was Yemen ahead.
Dominica ranks 141st and Yemen ranks 141st of 183 countries.
Across the 2 decades both report, Dominica averaged higher in 1 and Yemen in 1.
Head to head by decade
| Decade | Dominica | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.3333 patients | 0 patients | 0.3333 patients | Dominica |
| 2010s | 0.2857 patients | 6 patients | 5.71 patients | Yemen |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Dominica or Yemen?
- Dominica, at 0 patients against 0 patients in Yemen as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Dominica and Yemen?
- 0 patients, with Dominica ahead.
- How many years of comparable data are there for Dominica and Yemen?
- 10 years are reported by both, from 2006 to 2018.
- How do Dominica and Yemen rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Dominica ranks 141st and Yemen ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.